Back to Market Feed

Product Information

BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE is a generic product labeled by Endo USA Inc., priced at $2.4028 per EA under NDC 49884015154. Its NADAC has been published 142 times since Jan 17, 2024.

FDA first approved this application on Mar 6, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE

Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride
$2.4028per EA

Strength

140; 125; 125 mg/1; mg/1; mg/1

Manufacturer

Endo USA Inc.

NDC

49884015154

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

9/23/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205770

FDA Approved

3/6/2023

TE Code

AB

On Market Since

3/7/2023

Pharmacological Classes

Bismuth
Bismuth
Nitroimidazole Antimicrobial
Nitroimidazoles
Tetracycline-class Antimicrobial
Tetracyclines

Price Statistics

The NADAC for BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE has been published 142 times since Jan 17, 2024, and over the history we have for it it has declined 53.1%. The table below summarizes its recorded NADAC range and movement.

Current price$2.4028 per EA
All-time high$5.1282 (Feb 14, 2024)
All-time low$2.3760 (Aug 19, 2026)
52-week high$3.6473
52-week low$2.3760
Median price$3.5984
Average price$3.5313
Largest weekly change-22.6% (Jul 17, 2024)
Weeks tracked142
Tracking sinceJan 17, 2024

Price History

1W

0.0%

1M

+1.1%

3M

+0.5%

6M

-23.8%

1Y

-34.1%

3Y

N/A

5Y

N/A

All

-53.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

STOMACH RELIEF 525 MG/15 ML
Generic
70000004501•Cardinal Health
$0.0096
per ML
HM STOMACH RELIEF 525 MG/15 ML
Generic
62011043601•Strategic Sourcing Services LLC
$0.0100
per ML
HM STOMACH RELIEF 525 MG/30 ML
Generic
62011043501•Strategic Sourcing Services LLC
$0.0106
per ML
SM STOMACH RELIEF 525 MG/30 ML
Generic
70677009401•Strategic Sourcing Services LLC
$0.0106
per ML
STOMACH RELIEF 525 MG/15 ML
Generic
00536128736•Rugby Laboratories
$0.0107
per ML
GNP PINK BISMUTH 525 MG/15 ML
Generic
46122074706•AmerisourceBergen
$0.0121
per ML
STOMACH RLF 525 MG/30 ML SUSP
Generic
00536128636•Rugby Laboratories
$0.0124
per ML
STOMACH RELIEF 525 MG/30 ML
Generic
70000069801•Cardinal Health
$0.0126
per ML
FT STOMACH RELIEF 525 MG/30 ML
Generic
70677119101•Strategic Sourcing Services LLC
$0.0126
per ML
GNP STOMACH RLF 525 MG/30 ML
Generic
46122070326•AmerisourceBergen
$0.0168
per ML

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Manufacturer

Endo USA Inc. manufacturer profile

See the full portfolio, pricing trend, and other products from this labeler.

Drug market

Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride market comparison

Compare this molecule across participating manufacturers and inspect the broader market price spread.

Therapeutic class

Bismuth class view

See how this drug behaves alongside other products in the same FDA pharmacologic class.

Trend hub

Latest market trends

Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.

Guide

Understanding NADAC pricing

Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.

Frequently asked questions

What is the NADAC price of BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE, manufactured by Endo USA Inc., is $2.4028 per EA (NDC 49884015154), effective Sep 30, 2026.

How has the price of BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE has declined 53.1%. It has been tracked across 142 weekly CMS publications since Jan 17, 2024.

What are the highest and lowest recorded NADAC prices for BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE?

Since Jan 17, 2024, the NADAC for BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE has ranged from a low of $2.3760 (Aug 19, 2026) to a high of $5.1282 (Feb 14, 2024), with a median of $3.5984 per EA.

Are there cheaper alternatives to BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE?

BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE (NDC 49884015154) is labeled by Endo USA Inc., and CMS classifies it as a generic product.